Clinical trial paper that made anemia drug look safer than it is will be retracted
A study that a pharmaceutical company admitted last month included manipulated data will be retracted, Retraction Watch has learned. The paper, “Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis,” was published in Kidney International Reports in December 2020. The study analyzed data from a clinical trial for roxadustat, a … Continue reading Clinical trial paper that made anemia drug look safer than it is will be retracted